UCHL1 and myeloid sarcoma: It is hypothesized that the measurement of circulating neuroglial proteins levels such as UCHL1 in the CSF or blood can be used to detect and assess injury to the nervous system in neurological diseases and trauma, such as MS, amyotrophic lateral sclerosis (ALS), stroke, or traumatic brain injury (TBI)31,32.